Bergamaschi, Roberto, Marco Capobianco, and Roberto Ravasio. 2024. “Budget Impact Analysis of Natalizumab Biosimilar on Pharmaceutical Expenditure for the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy”. AboutOpen 11 (1):48-56. https://doi.org/10.33393/ao.2024.3078.